Takeda Ireland selects QUMAS DocCompliance for electronic document management throughout Manufacturing & Quality

JERSEY CITY, NJ - May 18, 2010 - QUMAS, the leading provider of Compliance Solutions to highly regulated companies, today announced that Takeda Ireland has selected QUMAS DocCompliance, an industry leading electronic document management system, for document control and compliance management across their manufacturing and quality operations.

"Given the ever changing regulatory landscape, organizations find it extremely challenging to quickly identify, assemble, review, approve, and distribute all the relevant documents for compliance," said Ken Hayward, CTO QUMAS. "With QUMAS, Takeda Ireland can deploy a solution that helps them operate in a continuous state of compliance at all times, even as new regulations come to the forefront."
With QUMAS DocCompliance, Takeda Ireland will automate the lifecycles of controlled documents, reducing review and approval cycle times and ensuring audit-readiness.

"We are very impressed with the robust functionality combined with the ease of use of the QUMAS solution," said John Cooney, Director of Quality Assurance, Takeda Ireland. "A single centralized system for the control of documentation, which can be integrated into our existing IT systems, will lead to greater efficiencies and compliance for Takeda Ireland and is seen as a key component in our Lean Transformation program."


QUMAS is the leader in Enterprise Compliance Solutions with more than 250 global customer deployments and over 15 years of experience helping companies in highly regulated industries. For more information visit www.qumas.com.

About Takeda Ireland

A wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, Takeda Ireland has been in operation since 1999. Takeda Ireland has served as Takeda's main Pharmaceutical production base for the European and U.S. markets. Takeda is striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products.
Takeda Ireland Limited has a solid oral dosage pharmaceutical manufacturing facility based in Bray, Co. Wicklow, Ireland and an API facility in Grange Castle, Dublin, Ireland. For more information visit www.takeda.ie.

All trade names, trademarks, and service marks are rightful property of their respective owners.